Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout
The recently discovered CRISPR/Cas9 system is widely used in basic research and is a useful tool for disease modeling and gene editing therapies. However, long-term expression of DNA-modifying enzymes can be associated with cytotoxicity and is particularly unwanted in clinical gene editing strategie...
Saved in:
Main Authors: | Yvonne Knopp (Author), Franziska K. Geis (Author), Dirk Heckl (Author), Stefan Horn (Author), Thomas Neumann (Author), Johannes Kuehle (Author), Janine Meyer (Author), Boris Fehse (Author), Christopher Baum (Author), Michael Morgan (Author), Johann Meyer (Author), Axel Schambach (Author), Melanie Galla (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
by: He X, et al.
Published: (2022)
by: He X, et al.
Published: (2022)
Similar Items
-
Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells
by: Yvonne Baron, et al.
Published: (2022) -
Production of Knockout Mice using CRISPR/Cas9 in FVB Strain
by: Hee Sook Bae, et al.
Published: (2015) -
User-Friendly Genetic Conditional Knockout Strategies by CRISPR/Cas9
by: Liangliang Chen, et al.
Published: (2018) -
Prevention of Avian Retrovirus Infection in Chickens Using CRISPR-Cas9 Delivered by Marek's Disease Virus
by: Kai Li, et al.
Published: (2020) -
Utilization of proliferable extracellular amastigotes for transient gene expression, drug sensitivity assay, and CRISPR/Cas9-mediated gene knockout in Trypanosoma cruzi.
by: Yuko Takagi, et al.
Published: (2019)